Near-infrared light therapy for mild to moderate Alzheimer's
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether shining a special near-infrared light on the head can help people with mild to moderate Alzheimer's disease. The light is thought to improve brain cell function and reduce damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 90 years old.
- You have been diagnosed with mild to moderate Alzheimer's disease (MMSE score 12 to 26).
- You have at least a primary school education and can complete thinking and memory tests.
- If you take memory medications, the dose has been the same for at least 3 months.
- You are not currently taking blood thinners.
- You have not had a seizure or hemorrhagic stroke in the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special near-infrared light device, combined with the medication lecanemab, can help people with mild Alzheimer's disease. It aims to see if the light therapy can slow down memory loss and improve daily function.
This study tests whether regular at-home “gamma” light and sound stimulation can help people with mild Alzheimer’s. Participants start with a month at home and are followed to see how they do during treatment.
This study tests whether far-infrared therapy (a gentle heat treatment) can help people with Alzheimer's dementia. If you have mild-to-moderate Alzheimer's on medication, you may be able to join.
This study tests whether daily exposure to special lights and sounds at 40 Hz can improve memory and thinking in people with early Alzheimer's disease. It aims to see if this non-invasive approach can help slow down cognitive decline.
This trial tests whether a combination of 40 Hz light stimulation and cognitive (thinking) therapy can improve symptoms in people with Alzheimer’s disease. It may help by stimulating the brain and training thinking skills, while carefully checking eye and seizure history.
This study tests whether regular “gamma” light and sound stimulation can delay or prevent Alzheimer’s disease-related memory decline in people who are currently not showing dementia but are at higher risk. It uses brain testing (MRI and PET) and memory/language tests over about 13 months.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.